Section Review—Cardiovascular & Renal: Recent Developments in Antithrombotic Agents
- 1 May 1995
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 4 (5) , 389-412
- https://doi.org/10.1517/13543784.4.5.389
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparinBlood Coagulation & Fibrinolysis, 1992
- DefibrotideCardiovascular Drug Reviews, 1991
- Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight HeparinsDrugs, 1990
- Comparative Antithrombotic and Hemorrhagic Effects of Dermatan Sulfate, Heparan Sulfate, and HeparinSeminars in Thrombosis and Hemostasis, 1989
- Therapeutic Potential of Non-Heparin Glycosaminoglycans of Natural OriginSeminars in Thrombosis and Hemostasis, 1989
- Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosisBritish Journal of Surgery, 1988
- TiclopidineDrugs, 1987
- Clinical Efficacy of Heparin Fractions: Issues and AnswersCRC Critical Reviews in Clinical Laboratory Sciences, 1986
- Sequence variation in heparin octasaccharides with high affinity for antithrombin IIIBiochemistry, 1984
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983